HD-OPM Archive
Topics › GLP-1 drugs (semaglutide, tirzepatide)

Medicare to cover GLP-1 obesity drugs for $50/month copay for BMI over 35

Louis Nervegna · Jun 30, 2026 · ♥ 8 reactions · 4 comments · original Facebook post
GLP-1 drugs (semaglutide, tirzepatide)Guidelines, policy & public healthWeight, visceral & liver fat
AI summary & key facts

Louis shares a CNBC report that Medicare will for the first time cover GLP-1 drugs for obesity, with a $50 monthly copay. He states it applies to beneficiaries with a BMI over 35. This is a coverage news item with no research behind it.

Anyone on Medicare in the USA with a BMI over 35 will soon be able to get GLP1 drugs for $50/month.

Quoted:

Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs.

Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It’s a watershed move that could unlock a vast new patient population for Novo Nordisk and Eli Lilly and dramatically expand access to medications that were previously out of reach for many people ages 65 and above.

CNBC's Annika Kim Constantino reports.

Read full report: cnb.cx/4y3nZCS

#glp1HD #medicareHD

← newer: The brain makes its own cholesterol and does not use cholestolder: Long COVID linked to higher risk of venous and arterial bloo →